Acorah Software Products - Accounts Production 16.0.110 false true 31 March 2023 1 April 2022 false 1 April 2023 31 March 2024 31 March 2024 06652129 Mr Andrew Arnold Mr Jeremy Goodhead Mr Ean David Andrews-Whalley iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 06652129 2023-03-31 06652129 2024-03-31 06652129 2023-04-01 2024-03-31 06652129 frs-core:CurrentFinancialInstruments 2024-03-31 06652129 frs-core:ComputerEquipment 2023-04-01 2024-03-31 06652129 frs-core:FurnitureFittings 2024-03-31 06652129 frs-core:FurnitureFittings 2023-04-01 2024-03-31 06652129 frs-core:FurnitureFittings 2023-03-31 06652129 frs-core:PlantMachinery 2024-03-31 06652129 frs-core:PlantMachinery 2023-04-01 2024-03-31 06652129 frs-core:PlantMachinery 2023-03-31 06652129 frs-core:ShareCapital 2024-03-31 06652129 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 06652129 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 06652129 frs-bus:FilletedAccounts 2023-04-01 2024-03-31 06652129 frs-bus:SmallEntities 2023-04-01 2024-03-31 06652129 frs-bus:AuditExempt-NoAccountantsReport 2023-04-01 2024-03-31 06652129 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 06652129 frs-core:UnlistedNon-exchangeTraded 2024-03-31 06652129 frs-core:UnlistedNon-exchangeTraded 2023-03-31 06652129 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-03-31 06652129 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 06652129 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 06652129 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-03-31 06652129 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 06652129 frs-bus:Director1 2023-04-01 2024-03-31 06652129 frs-bus:Director2 2023-04-01 2024-03-31 06652129 frs-bus:Director3 2023-04-01 2024-03-31 06652129 frs-core:CurrentFinancialInstruments 1 2024-03-31 06652129 frs-core:CurrentFinancialInstruments 3 2024-03-31 06652129 frs-countries:EnglandWales 2023-04-01 2024-03-31 06652129 2022-03-31 06652129 2023-03-31 06652129 2022-04-01 2023-03-31 06652129 frs-core:CurrentFinancialInstruments 2023-03-31 06652129 frs-core:ShareCapital 2023-03-31 06652129 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31 06652129 frs-core:CurrentFinancialInstruments 1 2023-03-31 06652129 frs-core:CurrentFinancialInstruments 3 2023-03-31
Registered number: 06652129
Serve Medical Limited
Unaudited Financial Statements
For The Year Ended 31 March 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—5
Page 1
Balance Sheet
Registered number: 06652129
2024 2023
Notes £ £ £ £
FIXED ASSETS
Tangible Assets 4 40,121 51,596
Investments 5 49,585 -
89,706 51,596
CURRENT ASSETS
Debtors 6 203,274 239,291
Cash at bank and in hand 458,178 338,588
661,452 577,879
Creditors: Amounts Falling Due Within One Year 7 (248,382 ) (193,367 )
NET CURRENT ASSETS (LIABILITIES) 413,070 384,512
TOTAL ASSETS LESS CURRENT LIABILITIES 502,776 436,108
PROVISIONS FOR LIABILITIES
Deferred Taxation (7,623 ) (10,164 )
NET ASSETS 495,153 425,944
CAPITAL AND RESERVES
Called up share capital 8 500 500
Profit and Loss Account 494,653 425,444
SHAREHOLDERS' FUNDS 495,153 425,944
Page 1
Page 2
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Ean David Andrews-Whalley
Director
30/07/2024
The notes on pages 3 to 5 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Serve Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 06652129 . The registered office is The Ercall Suite, Business Development Centre, Telford, Shropshire, TF3 3BA. The principal place of business is C8,10 Hortonwood, Telford TF1 7ES.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 10% straight line
Fixtures & Fittings Various
Computer Equipment 33% straight line
2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and asset reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 13 (2023: 13)
13 13
Page 3
Page 4
4. Tangible Assets
Plant & Machinery Fixtures & Fittings Total
£ £ £
Cost
As at 1 April 2023 101,310 24,498 125,808
Additions 1,229 - 1,229
As at 31 March 2024 102,539 24,498 127,037
Depreciation
As at 1 April 2023 55,025 19,187 74,212
Provided during the period 10,131 2,573 12,704
As at 31 March 2024 65,156 21,760 86,916
Net Book Value
As at 31 March 2024 37,383 2,738 40,121
As at 1 April 2023 46,285 5,311 51,596
5. Investments
Unlisted
£
Cost
As at 1 April 2023 -
Additions 49,585
As at 31 March 2024 49,585
Provision
As at 1 April 2023 -
As at 31 March 2024 -
Net Book Value
As at 31 March 2024 49,585
As at 1 April 2023 -
6. Debtors
2024 2023
£ £
Due within one year
Trade debtors 192,708 235,472
Prepayments and accrued income 9,423 2,268
Other debtors 1,143 1,551
203,274 239,291
Page 4
Page 5
7. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 58,516 46,599
Corporation tax 41,833 19,191
Other taxes and social security 10,692 14,253
VAT 38,099 48,990
Other creditors 11,542 11,542
Credit card 4,011 2,647
Pension fund 2,530 2,723
Accruals and deferred income 81,159 47,422
248,382 193,367
8. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 500 500
Page 5